JPRN-jRCT2080221559未知2 期
A Phase 2, Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Assess the Efficacy and Safety of AZD8931 In Combination With Anastrozole, Compared to Anastrozole Alone, in Post Menopausal Women With Hormone Receptor Positive, Endocrine Therapy Naive, Locally Advanced or Metastatic Breast Cancer
试验速览
- 阶段
- 2 期
- 发起方
- AstraZeneca
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- Female
入选标准
- •Patients that have locally advanced or metastatic breast cancer. Lesions should not be amenable to surgery or radiation of curative intent
- •- Hormone therapy-naive
- •- Estimated life expectancy of more than 12 weeks
排除标准
- •- Last dose of prior anti-cancer therapy received within 14 days (or longer if required)
- •- Any eye injury or corneal surgery within 3 months prior to receiving first dose of study drug.
- •- Currently receiving (and unwilling to discontinue) oestrogen replacement therapy. (last dose <7 days prior to randomisation)
研究者
相似试验
进行中（未招募）
1 期
A Phase 2, Randomised, Double-blind, Placebo-controlled, Dose-finding Study of Darbepoetin alfa for the Treatment of Anemia in Paediatric Subjects with Solid Tumours Receiving Cyclic ChemotherapyChemotherapy-induced anemia (CIA)MedDRA version: 9.1Level: LLTClassification code 10064469Term: Anemia post chemotherapyEUCTR2008-001721-34-BEAmgen Inc225
招募中
2 期
An Exploratory Phase 2, Randomised, Double-blind, Placebo-controlled Study to Evaluate the Treatment Effect of Pentosan Polysulfate Sodium Compared with Placebo on Synovial Fluid Biomarkers in Participants with Knee Osteoarthritis PaiMusculoskeletal - OsteoarthritisMusculoskeletal - Other muscular and skeletal disordersInflammatory and Immune System - Other inflammatory or immune system disordersKnee OsteoarthritisACTRN12621000136808Paradigm Biopharmaceuticals Pty Ltd60
已完成
2 期
Study to assess the safety and effectiveness of propagermanium as add-on therapy in Diabetic Kidney Disease (DKD) patients who are already taking IrbesartaDiabetic Kidney Disease (DKD)Renal and Urogenital - Kidney diseaseMetabolic and Endocrine - DiabetesACTRN12618000982213Dimerix Ltd45
进行中（未招募）
1 期
A clinical study with placebo to evaluate the safety and efficacy of BMS-986165 when used with background medication in patients with Lupus NephritisEUCTR2018-004142-42-BEBristol-Myers Squibb International Corporation113
进行中（未招募）
不适用
A Randomized Study comparing Placebo and ASP3652 in the treatment of women with Bladder Pain Syndrome / Interstitial CystitisEUCTR2011-004555-39-PLAstellas Pharma Europe B.V.300